The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch than the past two years.
President Biden’s Centers for Medicare and Medicaid Services on Friday proposed to increase the average benchmark payment to private Medicare Advantage plans by 2.2% for 2026. That compares to cuts of 0.2% for this year and 1.1% in 2024, although the Biden administration gave the Medicare Advantage industry one of the largest-ever payment hikes in 2023.
UnitedHealth Group is the largest seller of Medicare Advantage plans, followed by Humana and CVS Health. Together, those three companies cover nearly 60% of the market. UnitedHealth’s stock rose 2.4% after the close of regular trading, Humana climbed 3.3%, and CVS gained almost 2%.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.
Already have an account? Log in